Old Web
English
Sign In
Acemap
>
authorDetail
>
Yoshiaki Yanai
Yoshiaki Yanai
Otsuka Pharmaceutical
Sorafenib
Interferon
Cell growth
MAPK/ERK pathway
Combination therapy
2
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
2011
Cancer Immunology, Immunotherapy
Nobutaka Furuya
Takao Kamai
Hiromichi Shirataki
Yoshiaki Yanai
Takehiko Fukuda
Tomoya Mizuno
Fumihiko Nakamura
Tsunehito Kambara
Kimihiro Nakanishi
Hideyuki Abe
Ken-Ichiro Yoshida
Show All
Source
Cite
Save
Citations (15)
Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines
2008
Biomedical Research-tokyo
Shiro Tochizawa
Naoya Masumori
Yoshiaki Yanai
Yasukazu Ohmoto
Youichi Yabuuchi
Taiji Tsukamoto
Show All
Source
Cite
Save
Citations (15)
1